# A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects

> **NCT03527095** · PHASE1 · COMPLETED · sponsor: **Flatley Discovery Lab LLC** · enrollment: 11 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** FDL169

## Key facts

- **NCT ID:** NCT03527095
- **Lead sponsor:** Flatley Discovery Lab LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-05
- **Primary completion:** 2018-06-21
- **Final completion:** 2018-06-21
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03527095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03527095, "A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03527095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*